Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia 

Slides:



Advertisements
Similar presentations
Development of a Novel One-Tube Isothermal Reverse Transcription Thermophilic Helicase-Dependent Amplification Platform for Rapid RNA Detection James Goldmeyer,
Advertisements

CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Detection of Exon 12 Mutations in the JAK2 Gene
Denaturing High-Performance Liquid Chromatography
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
A Case of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia with a Rare FIP1L1 Breakpoint  Frédéric Lambert, Pierre Heimann, Christian Herens, Alain.
Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic.
Laboratory Practice Guidelines for Detecting and Reporting JAK2 and MPL Mutations in Myeloproliferative Neoplasms  Jerald Z. Gong, James R. Cook, Timothy.
Β-Glucuronidase Is an Optimal Normalization Control Gene for Molecular Monitoring of Chronic Myelogenous Leukemia  Joong Won Lee, Qiaofang Chen, Daniel.
Comprehensive Analysis of CBFβ-MYH11 Fusion Transcripts in Acute Myeloid Leukemia by RT-PCR Analysis  ShriHari S. Kadkol, Annette Bruno, Carol Dodge,
Tony L. Ng, Maureen J. O'Sullivan, Catherine J
Wanlong Ma, Hagop Kantarjian, Xi Zhang, Chen-Hsiung Yeh, Zhong J
Mutation Screening in Juvenile Polyposis Syndrome
Yanggu Shi, Sharon F. Terry, Patrick F. Terry, Lionel G
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Laboratory Diagnosis of Clostridium difficile Infection
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Philippe Szankasi, Mohamed Jama, David W. Bahler 
Ultrasensitive Detection of KRAS2 Mutations in Bile and Serum from Patients with Biliary Tract Carcinoma Using LigAmp Technology  Chanjuan Shi, Arjun.
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples  Prashanth Setty, Jennifer Hammes, Thomas Rothämel, Valentina.
A Clinical Grade Sequencing-Based Assay for CEBPA Mutation Testing
Down Syndrome and Malignancies: A Unique Clinical Relationship
Characterization of the Different BCR-ABL Transcripts with a Single Multiplex RT-PCR  Jacques Chasseriau, Jérôme Rivet, Frédéric Bilan, Jean-Claude Chomel,
Jeung-Yeal Ahn, Katie Seo, Olga Weinberg, Scott D. Boyd, Daniel A
A Tumor Sorting Protocol that Enables Enrichment of Pancreatic Adenocarcinoma Cells and Facilitation of Genetic Analyses  Zachary S. Boyd, Rajiv Raja,
Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions
Getting Things Backwards to Prevent Primer Dimers
Detection of an Apparent Homozygous 3120G>A Cystic Fibrosis Mutation on a Routine Carrier Screen  Denise LaMarche Heaney, Patrick Flume, Lauren Hamilton,
Chronic Myeloid Leukemia
Shaoyu Zhou, Keyaunoosh Kassauei, David J. Cutler, Giulia C
William L. Gerald, M.D., Ph.D, 1954–2008
SeqSharp The Journal of Molecular Diagnostics
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Multi-Site PCR-Based CMV Viral Load Assessment-Assays Demonstrate Linearity and Precision, but Lack Numeric Standardization  Daynna J. Wolff, Denise LaMarche.
Detection of Exon 12 Mutations in the JAK2 Gene
Molecular Characterization of WFS1 in Patients with Wolfram Syndrome
Benjamin P. Song, Surbhi Jain, Selena Y. Lin, Quan Chen, Timothy M
PIK3CA Hotspot Mutation Scanning by a Novel and Highly Sensitive High-Resolution Small Amplicon Melting Analysis Method  Panagiotis A. Vorkas, Nikoleta.
Cecily P. Vaughn, Kojo S.J. Elenitoba-Johnson 
The Molecular Pathology of Primary Immunodeficiencies
BCR-ABL1 RT-qPCR for Monitoring the Molecular Response to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia  Richard D. Press, Suzanne Kamel-Reid,
NRAS, NRAS, Which Mutation Is Fairest of Them All?
Ultrasensitive Detection of KRAS2 Mutations in Bile and Serum from Patients with Biliary Tract Carcinoma Using LigAmp Technology  Chanjuan Shi, Arjun.
Validation of Clinical Testing for Warfarin Sensitivity
Patients with Philadelphia-Positive Leukemia with BCR-ABL Kinase Mutations before Allogeneic Transplantation Predominantly Relapse with the Same Mutation 
Molecular Monitoring of Chronic Myelogenous Leukemia
Testing for Maternal Cell Contamination in Prenatal Samples
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
Microfluidic Deletion/Insertion Analysis for Rapid Screening of KIT and PDGFRA Mutations in CD117-Positive Gastrointestinal Stromal Tumors  Alberto Zamò,
Larissa V. Furtado, Helmut C. Weigelin, Kojo S. J
Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory  Jason.
Evaluating the Effect of Unclassified Variants Identified in MMR Genes Using Phenotypic Features, Bioinformatics Prediction, and RNA Assays  Lucia Pérez-Cabornero,
Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis  Marla Lay, Rajan Mariappan, Jason Gotlib, Lisa Dietz, Siby Sebastian,
Jianbo Song, Danielle Mercer, Xiaofeng Hu, Henry Liu, Marilyn M. Li 
Rapid and Sensitive Real-Time Polymerase Chain Reaction Method for Detection and Quantification of 3243A>G Mitochondrial Point Mutation  Rinki Singh,
Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic.
Feras M. Hantash, Arlene Rebuyon, Mei Peng, Joy B
A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing  Liying Zhang, Tomas Kirchhoff, Cindy.
Improved Detection of KIT Exon 11 Duplications in Formalin-Fixed, Paraffin-Embedded Gastrointestinal Stromal Tumors  Jerzy Lasota, Bartosz Wasag, Sonja.
Detection and Quantification of BCR-ABL1 Fusion Transcripts by Droplet Digital PCR  Lawrence J. Jennings, David George, Juliann Czech, Min Yu, Loren Joseph 
Karen Snow-Bailey, Ph.D., 1961–2006
Comprehensive Characterization of a Novel Intronic Pseudo-Exon Inserted within an e14/a2 BCR-ABL Rearrangement in a Patient with Chronic Myeloid Leukemia 
Molecular Diagnosis of Mast Cell Disorders
Fluorescence In Situ Hybridization Identifies Cryptic t(16;16)(p13;q22) Masked By del(16)(q22) in a Case of AML-M4 Eo  Shakil H. Merchant, Skip Haines,
Nathan D. Montgomery, Sara R. Selitsky, Nirali M. Patel, D
Tong Zhang, Sylvie Grenier, Bevoline Nwachukwu, Cuihong Wei, Jeffrey H
Characterization of a Recurrent Novel Large Duplication in the Cystic Fibrosis Transmembrane Conductance Regulator Gene  Feras M. Hantash, Joy B. Redman,
Monique A. Johnson, Marvin J. Yoshitomi, C. Sue Richards 
Presentation transcript:

Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia  Dan Jones, Suzanne Kamel-Reid, David Bahler, Henry Dong, Kojo Elenitoba-Johnson, Richard Press, Neil Quigley, Paul Rothberg, Dan Sabath, David Viswanatha, Karen Weck, James Zehnder  The Journal of Molecular Diagnostics  Volume 11, Issue 1, Pages 4-11 (January 2009) DOI: 10.2353/jmoldx.2009.080095 Copyright © 2009 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 1 Schematic of the BCR-ABL fusion transcript and the location of reported KD mutations and alternate transcripts. Common areas for location of BCR (blue box) and ABL1 (yellow box including KD) primers for nested PCR (blue arrows) and BCR-ABL KD PCR (red arrows) used for direct sequencing assays are indicated. Colored triangles indicate the location of KD mutations reported in TKI-resistant samples (black for imatinib, green for nilotinib/imatinib, blue for dasatinib/imatinib, and red for all three TKIs). The KD subdomains, exons, and amino acid numbers are shown. P-loop: phosphate binding loop; IM binding site: imatinib binding region; C-loop: kinase catalytic domain; and A-loop: activation loop. The locations of four deletions in the BCR-ABL transcript that were most commonly reported in our laboratory survey are included in the lower part of the figure. The Journal of Molecular Diagnostics 2009 11, 4-11DOI: (10.2353/jmoldx.2009.080095) Copyright © 2009 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions